Clene Inc. (NASDAQ: CLNN)
$4.4100
+0.0100 ( +0.92% ) 25.7K
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
Market Data
Open
$4.4100
Previous close
$4.4000
Volume
25.7K
Market cap
$35.43M
Day range
$4.2750 - $4.6350
52 week range
$3.8181 - $11.0000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 08, 2024 |
4 | Insider transactions | 1 | May 08, 2024 |
10-q | Quarterly Reports | 87 | May 08, 2024 |
4 | Insider transactions | 1 | May 01, 2024 |
8-k | 8K-related | 16 | Apr 26, 2024 |
ars | Annual reports | 1 | Apr 17, 2024 |
def | Proxies and info statements | 8 | Apr 16, 2024 |
8-k | 8K-related | 28 | Apr 16, 2024 |
4 | Insider transactions | 1 | Apr 16, 2024 |
8-k | 8K-related | 15 | Apr 09, 2024 |